bpc-157 / tb500 pen + TB-500 (Blend) - 5/5mg BodyPharm BPC157 & TB500 "Wolverine
Description
The former treatment had a shorter time of clinical improvement (17 weeks) compared to the latter (20 weeks)
It may be necessary to undergo multiple treatments in order to achieve optimal results
Tirzepatide is FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)
If the needle moves, it is in contact with the humeral head, if not, it is on the glenoid
Of note, the obtained evidence is complete (i.e., monocrotaline-treated rats develop significant pulmonary hypertension and marked RVe hypertrophy
